PRF Technologies (PRFX) Current Assets (2019 - 2025)
PRF Technologies' (PRFX) quarterly Current Assets came in at $4.4 million in Q4 2025, down 1.74% YoY from $4.4 million in Q4 2024, and up 11.31% on a QoQ basis from $3.9 million in Q2 2025.
PRF Technologies (PRFX) Current Assets (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Current Assets data on file, last reported at $4.4 million in Q4 2025.
- Quarterly Current Assets fell 1.74% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (down 1.74% YoY) and the FY2025 annual result came in at $4.4 million, down 1.74% from the prior year.
- Current Assets improved to $4.4 million in Q4 2025, from $3.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $21.3 million in Q1 2021 to a low of $371000.0 in Q4 2023.
- A 5-year average of $11.3 million and a median of $10.7 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets soared 3413.12% — and 2023, when it slumped 96.98%.
- Tracing PRFX's Current Assets over 5 years: stood at $19.0 million in 2021, then slumped by 35.42% to $12.3 million in 2022, then tumbled by 96.98% to $371000.0 in 2023, then jumped by 1093.53% to $4.4 million in 2024, then dropped by 1.74% to $4.4 million in 2025.
- The last three Current Assets figures came in at $4.4 million (Q4 2025), $3.9 million (Q2 2025), and $4.4 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.35 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Jun 30, 2024 | 2.99 Mn |
| Mar 31, 2024 | 5.25 Mn |
| Dec 31, 2023 | 371,000.00 |
| Sep 30, 2023 | 10.74 Mn |
| Jun 30, 2023 | 8.28 Mn |
| Mar 31, 2023 | 10.38 Mn |
| Dec 31, 2022 | 12.28 Mn |
| Sep 30, 2022 | 14.81 Mn |
| Jun 30, 2022 | 15.93 Mn |
| Mar 31, 2022 | 17.65 Mn |
| Dec 31, 2021 | 19.02 Mn |
| Sep 30, 2021 | 20.31 Mn |
| Jun 30, 2021 | 19.81 Mn |
| Mar 31, 2021 | 21.33 Mn |
| Dec 31, 2020 | 17.79 Mn |
| Jun 30, 2020 | 564,000.00 |
| Dec 31, 2019 | 972,000.00 |